Moderna’s COVID-19 vaccine gets panel support, set to become the second cleared by FDA for use in US

An advisory committee to the U.S. Food and Drug Administration has given a thumbs up to the nation's second COVID-19 vaccine.

The independent Vaccines and Related Biological Products Advisory Committee voted 20-0 with one abstention to support mRNA-1273, a vaccine made in collaboration with the U.S. government by Moderna, a decade-old Cambridge, Massachusetts-based biotechnology company.